|
| Clinical Research of Xinganbao and Lamivudinevir on Treating Chronic Type B Hepatitis |
| Hits 1299 Download times 1718 Received:August 12, 2006 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1673-9043.2007.01.09 |
| Key Words
chronic type B hepatitis;Xinganbao capsule;lamivudinevir |
| Author Name | Affiliation | | LIU Jian-hua | Tianjin Infectious Disease Hospital, Tianjin 300192, China | | YUAN Gui-yu | Tianjin Infectious Disease Hospital, Tianjin 300192, China |
|
| Abstract
|
| [Objective] To observe the clinical effect of Xinganbao capsule and lamivudinevir on treating chronic type B hepatitis and recudescent effect after stop using lamivudinevir [Methods] The sixtytwo patients were randomly divided into five groups: Xiaoyan Tang in advance combined with chemotherapy (ten days, seven days, three days);Xiaoyan Tang combined with chemotherapy;chemotherapygroup.[Results] The recidivismrate of using lamivudinevir for twentyfour months was obviously lower than that of using lamivudinevir for twelve months(P>0.05). The recidivism rate of using lamivudinevir and Xinganbao capsule for twelve and twentyfour months was obviously lower than that of using lamivudinevir for twelve and twentyfour months(P<0.05) [Conclusion] This method may decrrease recidivism rate of chronic type B heppatitis by delaying the curative course of lamivudinevir and combinatingwith Xinganbaocapsule. |
|
